Friday, January 13, 2017

What happens when prices are high and barriers to entry are not?

http://www.marketwatch.com/story/cvs-takes-on-mylans-epipen-with-much-cheaper-version-of-an-alternative-2017-01-12
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)